What Companies Are In The VanEck Semiconductor ETF?
There’s a lot to love about the VanEck Semiconductor ETF,…
Sell
45
DRUG Quote, Financials, Valuation and Earnings
Last price:
$39.35
Seasonality move
:
-32.13%
Day range:
$38.35 - $40.98
52-week range:
$0.93 - $79.02
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
67.97x
Volume:
49.2K
Avg. volume:
137.6K
1-year change:
2286.23%
Market cap:
$278.5M
Revenue:
--
EPS (TTM):
-$0.68
Earnings Data
Next earnings date for DRUG
--
Most recent earnings per share
-$0.12
Missed by $0.12
(Sep 30/2024)
Consensus Estimate
--
(Sep 30/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DRUG Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2024 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$0.12 | -- | -- |
| 06/30/2024 | Q2 | -- | -- | $0.04 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.32 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.30 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.29 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.40 | -- | -- |
| 02/14/2023 | Q4 | -- | -- | -$0.48 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.77 | -- | -- |
| 08/30/2022 | Q2 | -- | -- | -$0.88 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.50 | -- | -- |
| 02/14/2022 | Q4 | -- | -- | -$1.63 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.97 | -- | -- |
| 08/30/2021 | Q2 | -- | -- | -$1.26 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.91 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.41 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.02 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.02 | -- | -- |
Bright Minds Biosciences Earnings Questions
-
How Much did Bright Minds Biosciences Generate in Revenue Last Quarter?
Bright Minds Biosciences reported -- worth of top line sales in its most recent quarter.
-
Did Bright Minds Biosciences Beat Earnings Last Quarter?
Bright Minds Biosciences announced earnings per share of -$0.12 which represents a miss of analyst forecast a -- per share.
-
Is Bright Minds Biosciences Profitable?
Bright Minds Biosciences reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Bright Minds Biosciences EPS Next Year?
Bright Minds Biosciences's earnings are forecast to grow from -$0.48 per share to -- per share next year representing an increase of --.
-
When is Bright Minds Biosciences's Earnings Date?
Currently, Bright Minds Biosciences has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Can Palantir Stock Go?
Palantir Technologies (NASDAQ:PLTR) has been one of the undisputed victors…
Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Sell
39
DOGZ alert for Jan 4
Dogness (International) [DOGZ] is down 20.52% over the past day.
Buy
66
DMRC alert for Jan 4
Digimarc [DMRC] is up 16.19% over the past day.
Sell
39
MSTR alert for Jan 4
MicroStrategy [MSTR] is up 13.33% over the past day.
